Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in ...

Analysts surveyed by LSEG are expecting Amazon to report revenue of $187 billion for its latest quarter on Thursday.

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...

Oprah Winfrey is sharing new details on her weight loss in recent years, including the kind of weight loss drug she took. In a recent episode of "The Oprah Podcast", she said that she took a GLP-1 ...

Retatrutide has been shown to produce the greatest weight loss of any GLP-1. With the popularity of GLP-1 drugs, it's easy to forget that Eli Lilly has a deep roster of many other strong ...

Imagine this: You walk into your doctor and get your yearly flu vaccine and a yearly dose of your weight-loss injection. If Eli Lilly has its way, this may be the future of obesity care.

"Not all GLP-1s are the same." Retatrutide, the 'King Kong' drug to mimic bariatric surgery Eli Lilly isn't pivoting away from weekly weight loss injections entirely. It's also working on another ...

She showed off her new look and shocked fans Throughout her health journey, her fans seemed to notice her weight loss more than she did. “I don’t really see it because if anyone who’s on a ...

President Donald Trump signed an executive order pulling the U.S. out of the W.H.O. Winter health woes from the dangerous cold snap, and a Tennessee hospital breaks a heart transplant record. Bradley ...

Not to be outdone, Lilly is also working on a new “next-generation weight-loss drug” retatrutide, which targets three hormones: GLP-1, GIPR and glucagon. However, analysts have said that premilinary ...